G. Calvo-rojas

Dabigatran, Rivaroxaban, or Apixaban versus Warfarin in Patients with Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-Analysis of Subgroups

A. Gómez-Outes, M. Suárez-Gea, A. Terleira-Fernández, 2013, Thrombosis.

Streamlining cardiovascular clinical trials to improve efficiency and generalisability

Deepak L. Bhatt, D. Madigan, M. Pfeffer, 2017, Heart.

Direct oral anticoagulants for stroke prevention in patients with atrial fibrillation: meta-analysis by geographic region with a focus on European patients.

A. Gómez-Outes, M. Suárez-Gea, A. Terleira-Fernández, 2016, British journal of clinical pharmacology.

Causes of Death in Anticoagulated Patients With Atrial Fibrillation.

A. Gómez-Outes, M. Suárez-Gea, A. Terleira-Fernández, 2016, Journal of the American College of Cardiology.

Causes of Death in Patients with Venous Thromboembolism Anticoagulated with Direct Oral Anticoagulants: A Systematic Review and Meta-Analysis

R. Lecumberri, A. Gómez-Outes, M. Suárez-Gea, 2018, Seminars in Thrombosis and Hemostasis.

Discovery of anticoagulant drugs: a historical perspective.

R. Lecumberri, A. Gómez-Outes, E. Rocha, 2012, Current drug discovery technologies.

Reply

R. Lecumberri, G. Calvo-rojas, A. Gómez-Outes, 2021, Journal of the American College of Cardiology.

Meta-Analysis of Reversal Agents for Severe Bleeding Associated With Direct Oral Anticoagulants.

R. Lecumberri, A. Gómez-Outes, M. Suárez-Gea, 2021, Journal of the American College of Cardiology.

Causes of Death in Anticoagulated Patients With Atrial Fibrillation.

A. Gómez-Outes, M. Suárez-Gea, G. Calvo-rojas, 2016, Journal of the American College of Cardiology.